Tayla, A. Et Al. 2018. OSTEOPROTEGRIN RELATES WITH BIOMARKER THAT HAVE ROLES IN OSTEOPOROSIS, FIBROSIS, AND VASCULOPATHY IN SYSTEMIC SCLEROSIS: A POTENTIAL MULTIFACETED RELATIONSHIP BETWEEN OPG/RANKL/TRAIL AND WNT INHIBITOR. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.36, no.1 .

Tayla, A., Birlik, M., Kenar, G., Toprak, B., & Sisman, A., (2018). OSTEOPROTEGRIN RELATES WITH BIOMARKER THAT HAVE ROLES IN OSTEOPOROSIS, FIBROSIS, AND VASCULOPATHY IN SYSTEMIC SCLEROSIS: A POTENTIAL MULTIFACETED RELATIONSHIP BETWEEN OPG/RANKL/TRAIL AND WNT INHIBITOR. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.36, no.1.

Tayla, A. Et Al. "OSTEOPROTEGRIN RELATES WITH BIOMARKER THAT HAVE ROLES IN OSTEOPOROSIS, FIBROSIS, AND VASCULOPATHY IN SYSTEMIC SCLEROSIS: A POTENTIAL MULTIFACETED RELATIONSHIP BETWEEN OPG/RANKL/TRAIL AND WNT INHIBITOR," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.36, no.1, 2018

Tayla, A. Et Al. "OSTEOPROTEGRIN RELATES WITH BIOMARKER THAT HAVE ROLES IN OSTEOPOROSIS, FIBROSIS, AND VASCULOPATHY IN SYSTEMIC SCLEROSIS: A POTENTIAL MULTIFACETED RELATIONSHIP BETWEEN OPG/RANKL/TRAIL AND WNT INHIBITOR." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.36, no.1, 2018

Tayla, A. Et Al. (2018) . "OSTEOPROTEGRIN RELATES WITH BIOMARKER THAT HAVE ROLES IN OSTEOPOROSIS, FIBROSIS, AND VASCULOPATHY IN SYSTEMIC SCLEROSIS: A POTENTIAL MULTIFACETED RELATIONSHIP BETWEEN OPG/RANKL/TRAIL AND WNT INHIBITOR." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.36, no.1.

@article{article, author={A. Tayla Et Al. }, title={OSTEOPROTEGRIN RELATES WITH BIOMARKER THAT HAVE ROLES IN OSTEOPOROSIS, FIBROSIS, AND VASCULOPATHY IN SYSTEMIC SCLEROSIS: A POTENTIAL MULTIFACETED RELATIONSHIP BETWEEN OPG/RANKL/TRAIL AND WNT INHIBITOR}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2018}